EFNS guidelines for the diagnosis and management of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

http://www.wikidata.org/entity/Q51037908

about

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)What can imaging tell us about cognitive impairment and dementia?Alzheimer's disease and its treatment costs: case study in the Czech Republic Blood markers of oxidative stress in Alzheimer's disease Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease An algorithmic approach to structural imaging in dementia Dementia: timely diagnosis and early intervention MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study.Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Neuroimaging in a memory assessment service: a completed audit cycle.Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.A neurodegenerative vascular burden index and the impact on cognition.Structural MRI.The use of CT in dementia.Quality of dementia clinical guidelines and relevance to the care of older people with comorbidity: evidence from the literature The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.UPDATE ON DEMENTIA WITH LEWY BODIES.Brain aging and dementia during the transition from late adulthood to old age: design and methodology of the "Invece.Ab" population-based study.Driving and dementia: a clinical decision pathway.Why does mommy forget?Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease Alzheimer's disease: a clinical practice-oriented review.Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer's disease in daily practice.Relationship between the gene polymorphisms of kallikrein-kinin system and Alzheimer's disease in a Hunan Han Chinese population Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer's Disease Quantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome.Suspected early dementia.MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.Clinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai.The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland.Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges

P2860

Q24197659-9ABB147C-FF79-4152-B9DF-4A5EA8DA003C Q26749292-0374B4C4-B3CD-4E7B-B742-A43D9F4E62FF Q26781954-2920F2E9-AB51-4C6D-A11A-9308631E77DC Q27021625-7466A259-F583-412F-A982-AB05940A90D7 Q27025207-AD8DA111-0608-4D37-AFDC-41442524B5F4 Q27025567-7D333D70-F48C-43D6-BF31-DD8543CFAB9F Q28082444-6F18AF1D-EC08-4BAC-A30F-EEC2D25FE80F Q30540746-721EED0B-6C74-480B-A3A4-1AEABB333087 Q30571571-B036233C-00CA-4567-969E-2FC3930A4DD6 Q30591744-0FB92AA4-3A88-436F-8170-7C279E28DAB7 Q30845482-2DA4933C-FCB2-44C1-B6B3-CAB24F9534BF Q30996675-08DDCFC7-9E2F-457E-B9FE-AE5BF6C2E5D6 Q31155412-D8F60B82-2BAC-4FBF-9752-50AF96FB2FE2 Q33454879-C8D732D7-D2C6-42B4-BE41-D493D630BE48 Q33556068-F4397BC0-122D-4218-94D1-70C59679D9F6 Q33795703-8CC5C7C7-E233-4F38-89D6-CB9082AE0BCF Q33800534-DB02430D-B835-4187-BB1F-FF903B2679AC Q33869926-DA851F56-4D34-490A-BA8B-67241496B704 Q33951159-162C595F-6D81-482D-B5CE-C675F74D2C38 Q33951165-F7F5035B-7978-43AE-AE59-F802145F70C2 Q34090081-BC56794E-BA23-4C31-978E-8D106F14B4EC Q34296479-6CB40AE6-8EA2-4A71-A9FA-91A8E86B1C40 Q34450376-791BD1AC-CB56-408B-88BE-3596E779A348 Q34996345-26D0CD32-2875-49AA-B2C3-1D1CF24F9136 Q35008622-27A54293-A4A0-4552-85B3-DB5CAF0D3215 Q35252193-9F917562-763D-41E0-9D0A-BE86FE34F7DE Q35284971-A2A74D13-0895-4ECF-93A5-D5F1EC7F3929 Q35899503-2EECAEC6-34D1-417A-95BF-FFAA57FBB5E0 Q35905814-914BF1F3-8724-42FE-AEA0-8175607A4524 Q35925677-36E7887F-29B5-4FF5-8CC4-2999598B17B6 Q36093127-4B1237F8-8411-450C-BB70-C6BE5912E682 Q36204169-041E7FA0-D7B8-4149-8D72-9AEAC2B675FA Q36322982-88AE3433-62B1-47DA-94F7-24BBBDB7BF21 Q36325825-9B1E523B-B730-40CE-AC29-4A75AE0D3B5A Q36363685-8C49B2CA-19B1-49EC-8AA3-D2E0541A35C7 Q36724441-A9C2A86B-6103-499B-AC53-BAB90322EDBC Q36830837-F4330486-DBFF-417B-A1A1-A226EA99B8D6 Q36915278-E1D4B33B-B2B1-459F-ACAA-11E8F0963067 Q36926723-C6162854-E6DF-4820-934E-AB6B4544F007 Q37053888-1A3F4A82-F582-4153-A349-596B96747C54

P2860

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

http://www.wikidata.org/entity/Q51037908

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

@en

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

@nl

type

label

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

@en

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

@nl

prefLabel

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

@en

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

@nl

P1433

Q51037908-93F6C6FD-6376-468E-9E0D-40922B43F853

P1476

Q51037908-C119D4D7-848F-4EA9-8AEA-38172A5245BB

P2093

Q51037908-143331FF-0C7F-4E25-AEC2-76F55FC45311

Q51037908-3CAA39D7-7DBB-4676-99EA-1D54C578A195

Q51037908-3DC8CE67-6578-4704-886B-42A872DC440C

Q51037908-4277A30E-1570-4DF5-8DC0-FA765224A00F

Q51037908-683D0791-7A63-4836-BF93-934938E030FF

Q51037908-842F1927-8CAC-4542-876A-B2362F9D5700

Q51037908-C79D6E10-EEF0-4B72-9919-5DCDCEE90D0E

P2860

Q51037908-0556291C-BA97-4B97-B111-9DDB08D6B650

Q51037908-055AB7F7-70E8-4D9C-BC59-ACF9F0B948D5

Q51037908-07107C61-071B-4D5A-B69E-6B49EAC15DFF

Q51037908-072DA2DE-0965-42F6-B601-A353E901FEB2

Q51037908-076A7D94-06CB-48B1-9BDB-B4463EBCCADE

Q51037908-0CE2C4B0-B23C-4943-A78C-B9F8F1B99F39

Q51037908-0F74863E-5509-423A-8D95-A93E2B9CEFDE

Q51037908-110638FF-A408-45DC-A338-9A707B8E95BA

Q51037908-12AF2D69-0BF1-4BC7-AACB-51CCDACA4E27

Q51037908-157072DB-47E8-43E7-9F75-6DB17A7946D3

P304

Q51037908-02FDE850-79A6-4721-B350-D7878831CB41

P31

Q51037908-1FF56489-0283-4CB4-B670-684AC42A1075

P356

Q51037908-A77CABFA-50BD-4A41-9A7C-09A8543B49C4

P433

Q51037908-D9C8EF9D-099B-48ED-9845-77215BC44B2C

P478

Q51037908-A530E28B-EC6E-467B-BEFD-FA83714C74B3

P50

Q51037908-5F779AF6-8145-4005-AD8D-6193380A33E7

Q51037908-FAA08C97-2BD2-4D18-A3A6-7C7955A80120

P577

Q51037908-499FB79E-FC01-4A57-A68E-A75CF1BB3842

P5875

Q51037908-94E00406-412D-43E4-A704-533289C9C591

P698

Q51037908-D594CB16-3667-4D81-9660-447143E9C042

P356

J.1468-1331.2010.03040.X

P1433

European Journal of Neurology

P1476

EFNS guidelines for the diagnosis and management of Alzheimer's disease

@en

P2093

B O Popescu

http://www.w3.org/2001/XMLSchema#string

EFNS Scientist Panel on Dementia

http://www.w3.org/2001/XMLSchema#string

G Gainotti

http://www.w3.org/2001/XMLSchema#string

I Rektorova

http://www.w3.org/2001/XMLSchema#string

J Hort

http://www.w3.org/2001/XMLSchema#string

P Scheltens

http://www.w3.org/2001/XMLSchema#string

T Pirttila

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials

Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline

Global prevalence of dementia: a Delphi consensus study

Ecological implications of ideomotor apraxia: evidence from physical activities of daily living

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.

P304

1236-1248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1331.2010.03040.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227728550

http://www.w3.org/2001/XMLSchema#string

P698

20831773

http://www.w3.org/2001/XMLSchema#string